Beta-defensin 2: Difference between revisions
Jump to navigation
Jump to search
m Bot: HTTP→HTTPS (v470) |
consistent citation formatting |
||
| Line 1: | Line 1: | ||
{{Infobox_gene}} | {{Infobox_gene}} | ||
'''Beta-defensin 2''' (BD-2) also known as '''skin-antimicrobial peptide 1''' (SAP1) is a [[peptide]] that in humans is encoded by the ''DEFB4'' (defensin, beta 4) [[gene]].<ref name="pmid9202117">{{cite journal | vauthors = Harder J, Bartels J, Christophers E, | '''Beta-defensin 2''' (BD-2) also known as '''skin-antimicrobial peptide 1''' (SAP1) is a [[peptide]] that in humans is encoded by the ''DEFB4'' (defensin, beta 4) [[gene]].<ref name="pmid9202117">{{cite journal | vauthors = Harder J, Bartels J, Christophers E, Schröder JM | title = A peptide antibiotic from human skin | journal = Nature | volume = 387 | issue = 6636 | pages = 861 | date = June 1997 | pmid = 9202117 | pmc = | doi = 10.1038/43088 }}</ref> | ||
Human beta-defensin-2 (hBD-2) is a cysteine-rich cationic low molecular weight antimicrobial peptide recently discovered in lesional skin. | Human beta-defensin-2 (hBD-2) is a cysteine-rich cationic low molecular weight antimicrobial peptide recently discovered in lesional skin. | ||
| Line 6: | Line 6: | ||
== Structure == | == Structure == | ||
hBD-2 is a protein whose primary structure is made by 64 aminoacids. At concentrations ≤2.4 mM, hBD-2 is monomeric.<ref>{{cite journal | vauthors = Sawai MV, Jia HP, Liu L, Aseyev V, Wiencek JM, | hBD-2 is a protein whose primary structure is made by 64 aminoacids. At concentrations ≤2.4 mM, hBD-2 is monomeric.<ref>{{cite journal | vauthors = Sawai MV, Jia HP, Liu L, Aseyev V, Wiencek JM, McCray PB, Ganz T, Kearney WR, Tack BF | title = The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment | journal = Biochemistry | volume = 40 | issue = 13 | pages = 3810–6 | date = April 2001 | pmid = 11300761 | pmc = | doi = 10.1021/bi002519d }}</ref> The structure is [[amphiphilic]] with a nonuniform surface distribution of positive charge and contains several key structural elements, including a triple-stranded, antiparallel [[beta sheet]] with strands 2 and 3 in a [[beta hairpin]] conformation. | ||
The determination of other structural elements depends on the technique used. When X-ray crystallography is used an [[alpha helix]] can be observed at the [[ | The determination of other structural elements depends on the technique used. When X-ray crystallography is used an [[alpha helix]] can be observed at the [[N-terminus|N-terminal]] end of the protein (PDB codes: {{PDB2|1fd3}},{{PDB2|1fd4}}, and {{PDB2|6cs9}}). When using NMR this alpha-helix does not appear (PDB code: {{PDB2|1e4q}}), however this structure was determined using a truncated version of hBD-2 which was missing the initial 4 amino acids, and may be the reason for the discrepancy. | ||
== Function == | == Function == | ||
[[Defensin]]s form a family of microbicidal and [[cytotoxic]] peptides made by [[neutrophil]]s. Members of the defensin family are highly similar in protein sequence. Beta-defensin 2 is an antibiotic peptide which is locally regulated by [[inflammation]].<ref>{{cite web | title = Entrez Gene: DEFB4 defensin, beta 4| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1673| | [[Defensin]]s form a family of microbicidal and [[cytotoxic]] peptides made by [[neutrophil]]s. Members of the defensin family are highly similar in protein sequence. Beta-defensin 2 is an antibiotic peptide which is locally regulated by [[inflammation]].<ref>{{cite web | title = Entrez Gene: DEFB4 defensin, beta 4| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1673| access-date = }}</ref> | ||
Human beta-defensin 2 is produced by a number of [[epithelium|epithelial]] cells and exhibits potent antimicrobial activity against [[Gram-negative bacteria]] and ''[[Candida (genus)|Candida]]'', but not Gram-positive ''[[Staphylococcus aureus|S. aureus]]''. It has been speculated that beta-defensin 2 may contribute to the infrequency of Gram-negative infections on skin and lung tissue.<ref name="pmid10404637">{{cite journal | vauthors = Schröder JM, Harder J | title = Human beta-defensin-2 | journal = | Human beta-defensin 2 is produced by a number of [[epithelium|epithelial]] cells and exhibits potent antimicrobial activity against [[Gram-negative bacteria]] and ''[[Candida (genus)|Candida]]'', but not Gram-positive ''[[Staphylococcus aureus|S. aureus]]''. It has been speculated that beta-defensin 2 may contribute to the infrequency of Gram-negative infections on skin and lung tissue.<ref name="pmid10404637">{{cite journal | vauthors = Schröder JM, Harder J | title = Human beta-defensin-2 | journal = The International Journal of Biochemistry & Cell Biology | volume = 31 | issue = 6 | pages = 645–51 | date = June 1999 | pmid = 10404637 | doi = 10.1016/S1357-2725(99)00013-8 }}</ref> | ||
hBD-2 represents the first human defensin that is produced following stimulation of epithelial cells by contact with microorganisms such as ''[[Pseudomonas aeruginosa|P. aeruginosa]]'' or cytokines such as TNF-alpha and IL-1 beta. The HBD-2 gene and protein are locally expressed in [[keratinocytes]] associated with inflammatory skin lesions. It is intriguing to speculate that HBD-2 is a dynamic component of the local epithelial defense system of the skin and respiratory tract having a role to protect surfaces from infection, and providing a possible reason why skin and lung infections with Gram-negative bacteria are rather rare.<ref name="pmid10404637"/> | hBD-2 represents the first human defensin that is produced following stimulation of epithelial cells by contact with microorganisms such as ''[[Pseudomonas aeruginosa|P. aeruginosa]]'' or cytokines such as TNF-alpha and IL-1 beta. The HBD-2 gene and protein are locally expressed in [[keratinocytes]] associated with inflammatory skin lesions. It is intriguing to speculate that HBD-2 is a dynamic component of the local epithelial defense system of the skin and respiratory tract having a role to protect surfaces from infection, and providing a possible reason why skin and lung infections with Gram-negative bacteria are rather rare.<ref name="pmid10404637"/> | ||
Although this protein doesn’t have any antibacterial activity against Gram-positive bacteria, there is a study showing that there is a synergy between hBD-2 and other proteins.<ref name="pmid20485435">{{cite journal | | Although this protein doesn’t have any antibacterial activity against Gram-positive bacteria, there is a study showing that there is a synergy between hBD-2 and other proteins.<ref name="pmid20485435">{{cite journal | vauthors = Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y | title = Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization | journal = Nature | volume = 465 | issue = 7296 | pages = 346–9 | date = May 2010 | pmid = 20485435 | doi = 10.1038/nature09074 }}</ref> One example of this synergistic effect is with epiP, a protein segregated by some strains of ''[[Staphylococcus epidermidis|S. epidermidis]]''. hBD2, holding hands with epiP, is capable of killing ''[[Staphylococcus aureus|S. aureus]]'', a Gram-positive bacteria responsible of human diseases. | ||
==References== | == References == | ||
{{reflist}} | {{reflist}} | ||
==External links== | == External links == | ||
* {{UCSC gene info|DEFB4A}} | * {{UCSC gene info|DEFB4A}} | ||
==Further reading== | == Further reading == | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
*{{cite journal | * {{cite journal | vauthors = Weinberg A, Krisanaprakornkit S, Dale BA | title = Epithelial antimicrobial peptides: review and significance for oral applications | journal = Critical Reviews in Oral Biology and Medicine | volume = 9 | issue = 4 | pages = 399–414 | year = 1999 | pmid = 9825219 | doi = 10.1177/10454411980090040201 }} | ||
*{{cite journal | * {{cite journal | vauthors = Schröder JM, Harder J | title = Human beta-defensin-2 | journal = The International Journal of Biochemistry & Cell Biology | volume = 31 | issue = 6 | pages = 645–51 | date = June 1999 | pmid = 10404637 | doi = 10.1016/S1357-2725(99)00013-8 }} | ||
*{{cite journal | * {{cite journal | vauthors = Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM | title = Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung | journal = The Journal of Clinical Investigation | volume = 102 | issue = 5 | pages = 874–80 | date = September 1998 | pmid = 9727055 | pmc = 508952 | doi = 10.1172/JCI2410 }} | ||
*{{cite journal | * {{cite journal | vauthors = Liu L, Wang L, Jia HP, Zhao C, Heng HH, Schutte BC, McCray PB, Ganz T | title = Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation | journal = Gene | volume = 222 | issue = 2 | pages = 237–44 | date = November 1998 | pmid = 9831658 | doi = 10.1016/S0378-1119(98)00480-6 }} | ||
*{{cite journal | * {{cite journal | vauthors = Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, Tack BF, McCray PB | title = Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands | journal = Infection and Immunity | volume = 67 | issue = 6 | pages = 2740–5 | date = June 1999 | pmid = 10338476 | pmc = 96577 | doi = }} | ||
*{{cite journal | * {{cite journal | vauthors = Jia HP, Mills JN, Barahmand-Pour F, Nishimura D, Mallampali RK, Wang G, Wiles K, Tack BF, Bevins CL, McCray PB | title = Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins | journal = Infection and Immunity | volume = 67 | issue = 9 | pages = 4827–33 | date = September 1999 | pmid = 10456937 | pmc = 96815 | doi = }} | ||
*{{cite journal | * {{cite journal | vauthors = Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM, Oppenheim JJ | title = Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 | journal = Science | volume = 286 | issue = 5439 | pages = 525–8 | date = October 1999 | pmid = 10521347 | doi = 10.1126/science.286.5439.525 }} | ||
*{{cite journal | * {{cite journal | vauthors = Diamond G, Kaiser V, Rhodes J, Russell JP, Bevins CL | title = Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells | journal = Infection and Immunity | volume = 68 | issue = 1 | pages = 113–9 | date = January 2000 | pmid = 10603376 | pmc = 97109 | doi = 10.1128/iai.68.1.113-119.2000 }} | ||
*{{cite journal | * {{cite journal | vauthors = Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schröder JM | title = Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia | journal = American Journal of Respiratory Cell and Molecular Biology | volume = 22 | issue = 6 | pages = 714–21 | date = June 2000 | pmid = 10837369 | doi = 10.1165/ajrcmb.22.6.4023 }} | ||
*{{cite journal | * {{cite journal | vauthors = Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ, Chertov O, Lubkowski J | title = The structure of human beta-defensin-2 shows evidence of higher order oligomerization | journal = The Journal of Biological Chemistry | volume = 275 | issue = 42 | pages = 32911–8 | date = October 2000 | pmid = 10906336 | doi = 10.1074/jbc.M006098200 }} | ||
*{{cite journal | * {{cite journal | vauthors = Meyer JE, Harder J, Görögh T, Schröder JM, Maune S | title = [hBD-2 gene expression in nasal mucosa] | journal = Laryngo- Rhino- Otologie | volume = 79 | issue = 7 | pages = 400–3 | date = July 2000 | pmid = 11005092 | doi = 10.1055/s-2000-4626 }} | ||
*{{cite journal | * {{cite journal | vauthors = Ali RS, Falconer A, Ikram M, Bissett CE, Cerio R, Quinn AG | title = Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin | journal = The Journal of Investigative Dermatology | volume = 117 | issue = 1 | pages = 106–11 | date = July 2001 | pmid = 11442756 | doi = 10.1046/j.0022-202x.2001.01401.x }} | ||
*{{cite journal | * {{cite journal | vauthors = Carothers DG, Graham SM, Jia HP, Ackermann MR, Tack BF, McCray PB | title = Production of beta-defensin antimicrobial peptides by maxillary sinus mucosa | journal = American Journal of Rhinology | volume = 15 | issue = 3 | pages = 175–9 | year = 2001 | pmid = 11453504 | doi = 10.2500/105065801779954238 }} | ||
*{{cite journal | * {{cite journal | vauthors = Biragyn A, Surenhu M, Yang D, Ruffini PA, Haines BA, Klyushnenkova E, Oppenheim JJ, Kwak LW | title = Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens | journal = Journal of Immunology | volume = 167 | issue = 11 | pages = 6644–53 | date = December 2001 | pmid = 11714836 | doi = 10.4049/jimmunol.167.11.6644 }} | ||
*{{cite journal | * {{cite journal | vauthors = Bauer F, Schweimer K, Klüver E, Conejo-Garcia JR, Forssmann WG, Rösch P, Adermann K, Sticht H | title = Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity | journal = Protein Science | volume = 10 | issue = 12 | pages = 2470–9 | date = December 2001 | pmid = 11714914 | pmc = 2374044 | doi = 10.1110/ps.24401 }} | ||
*{{cite journal | * {{cite journal | vauthors = Takahashi A, Wada A, Ogushi K, Maeda K, Kawahara T, Mawatari K, Kurazono H, Moss J, Hirayama T, Nakaya Y | title = Production of beta-defensin-2 by human colonic epithelial cells induced by Salmonella enteritidis flagella filament structural protein | journal = FEBS Letters | volume = 508 | issue = 3 | pages = 484–8 | date = November 2001 | pmid = 11728477 | doi = 10.1016/S0014-5793(01)03088-5 }} | ||
*{{cite journal | * {{cite journal | vauthors = Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, McCray PB, Tack BF, Vogel HJ | title = The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus | journal = The Journal of Biological Chemistry | volume = 277 | issue = 10 | pages = 8279–89 | date = March 2002 | pmid = 11741980 | doi = 10.1074/jbc.M108830200 }} | ||
{{refend}} | {{refend}} | ||
{{PDB Gallery|geneid=1673}} | {{PDB Gallery|geneid=1673}} | ||
{{protein-stub}} | |||
[[Category:Defensins]] | |||
Revision as of 06:50, 28 July 2018
| VALUE_ERROR (nil) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Aliases | |||||||
| External IDs | GeneCards: [1] | ||||||
| Orthologs | |||||||
| Species | Human | Mouse | |||||
| Entrez |
|
| |||||
| Ensembl |
|
| |||||
| UniProt |
|
| |||||
| RefSeq (mRNA) |
|
| |||||
| RefSeq (protein) |
|
| |||||
| Location (UCSC) | n/a | n/a | |||||
| PubMed search | n/a | n/a | |||||
| Wikidata | |||||||
| |||||||
Beta-defensin 2 (BD-2) also known as skin-antimicrobial peptide 1 (SAP1) is a peptide that in humans is encoded by the DEFB4 (defensin, beta 4) gene.[1]
Human beta-defensin-2 (hBD-2) is a cysteine-rich cationic low molecular weight antimicrobial peptide recently discovered in lesional skin.
Structure
hBD-2 is a protein whose primary structure is made by 64 aminoacids. At concentrations ≤2.4 mM, hBD-2 is monomeric.[2] The structure is amphiphilic with a nonuniform surface distribution of positive charge and contains several key structural elements, including a triple-stranded, antiparallel beta sheet with strands 2 and 3 in a beta hairpin conformation. The determination of other structural elements depends on the technique used. When X-ray crystallography is used an alpha helix can be observed at the N-terminal end of the protein (PDB codes: 1fd3,1fd4, and 6cs9). When using NMR this alpha-helix does not appear (PDB code: 1e4q), however this structure was determined using a truncated version of hBD-2 which was missing the initial 4 amino acids, and may be the reason for the discrepancy.
Function
Defensins form a family of microbicidal and cytotoxic peptides made by neutrophils. Members of the defensin family are highly similar in protein sequence. Beta-defensin 2 is an antibiotic peptide which is locally regulated by inflammation.[3]
Human beta-defensin 2 is produced by a number of epithelial cells and exhibits potent antimicrobial activity against Gram-negative bacteria and Candida, but not Gram-positive S. aureus. It has been speculated that beta-defensin 2 may contribute to the infrequency of Gram-negative infections on skin and lung tissue.[4]
hBD-2 represents the first human defensin that is produced following stimulation of epithelial cells by contact with microorganisms such as P. aeruginosa or cytokines such as TNF-alpha and IL-1 beta. The HBD-2 gene and protein are locally expressed in keratinocytes associated with inflammatory skin lesions. It is intriguing to speculate that HBD-2 is a dynamic component of the local epithelial defense system of the skin and respiratory tract having a role to protect surfaces from infection, and providing a possible reason why skin and lung infections with Gram-negative bacteria are rather rare.[4]
Although this protein doesn’t have any antibacterial activity against Gram-positive bacteria, there is a study showing that there is a synergy between hBD-2 and other proteins.[5] One example of this synergistic effect is with epiP, a protein segregated by some strains of S. epidermidis. hBD2, holding hands with epiP, is capable of killing S. aureus, a Gram-positive bacteria responsible of human diseases.
References
- ↑ Harder J, Bartels J, Christophers E, Schröder JM (June 1997). "A peptide antibiotic from human skin". Nature. 387 (6636): 861. doi:10.1038/43088. PMID 9202117.
- ↑ Sawai MV, Jia HP, Liu L, Aseyev V, Wiencek JM, McCray PB, Ganz T, Kearney WR, Tack BF (April 2001). "The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment". Biochemistry. 40 (13): 3810–6. doi:10.1021/bi002519d. PMID 11300761.
- ↑ "Entrez Gene: DEFB4 defensin, beta 4".
- ↑ 4.0 4.1 Schröder JM, Harder J (June 1999). "Human beta-defensin-2". The International Journal of Biochemistry & Cell Biology. 31 (6): 645–51. doi:10.1016/S1357-2725(99)00013-8. PMID 10404637.
- ↑ Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y (May 2010). "Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization". Nature. 465 (7296): 346–9. doi:10.1038/nature09074. PMID 20485435.
External links
- Human DEFB4A genome location and DEFB4A gene details page in the UCSC Genome Browser.
Further reading
- Weinberg A, Krisanaprakornkit S, Dale BA (1999). "Epithelial antimicrobial peptides: review and significance for oral applications". Critical Reviews in Oral Biology and Medicine. 9 (4): 399–414. doi:10.1177/10454411980090040201. PMID 9825219.
- Schröder JM, Harder J (June 1999). "Human beta-defensin-2". The International Journal of Biochemistry & Cell Biology. 31 (6): 645–51. doi:10.1016/S1357-2725(99)00013-8. PMID 10404637.
- Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM (September 1998). "Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung". The Journal of Clinical Investigation. 102 (5): 874–80. doi:10.1172/JCI2410. PMC 508952. PMID 9727055.
- Liu L, Wang L, Jia HP, Zhao C, Heng HH, Schutte BC, McCray PB, Ganz T (November 1998). "Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation". Gene. 222 (2): 237–44. doi:10.1016/S0378-1119(98)00480-6. PMID 9831658.
- Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, Tack BF, McCray PB (June 1999). "Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands". Infection and Immunity. 67 (6): 2740–5. PMC 96577. PMID 10338476.
- Jia HP, Mills JN, Barahmand-Pour F, Nishimura D, Mallampali RK, Wang G, Wiles K, Tack BF, Bevins CL, McCray PB (September 1999). "Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins". Infection and Immunity. 67 (9): 4827–33. PMC 96815. PMID 10456937.
- Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM, Oppenheim JJ (October 1999). "Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6". Science. 286 (5439): 525–8. doi:10.1126/science.286.5439.525. PMID 10521347.
- Diamond G, Kaiser V, Rhodes J, Russell JP, Bevins CL (January 2000). "Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells". Infection and Immunity. 68 (1): 113–9. doi:10.1128/iai.68.1.113-119.2000. PMC 97109. PMID 10603376.
- Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schröder JM (June 2000). "Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia". American Journal of Respiratory Cell and Molecular Biology. 22 (6): 714–21. doi:10.1165/ajrcmb.22.6.4023. PMID 10837369.
- Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ, Chertov O, Lubkowski J (October 2000). "The structure of human beta-defensin-2 shows evidence of higher order oligomerization". The Journal of Biological Chemistry. 275 (42): 32911–8. doi:10.1074/jbc.M006098200. PMID 10906336.
- Meyer JE, Harder J, Görögh T, Schröder JM, Maune S (July 2000). "[hBD-2 gene expression in nasal mucosa]". Laryngo- Rhino- Otologie. 79 (7): 400–3. doi:10.1055/s-2000-4626. PMID 11005092.
- Ali RS, Falconer A, Ikram M, Bissett CE, Cerio R, Quinn AG (July 2001). "Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin". The Journal of Investigative Dermatology. 117 (1): 106–11. doi:10.1046/j.0022-202x.2001.01401.x. PMID 11442756.
- Carothers DG, Graham SM, Jia HP, Ackermann MR, Tack BF, McCray PB (2001). "Production of beta-defensin antimicrobial peptides by maxillary sinus mucosa". American Journal of Rhinology. 15 (3): 175–9. doi:10.2500/105065801779954238. PMID 11453504.
- Biragyn A, Surenhu M, Yang D, Ruffini PA, Haines BA, Klyushnenkova E, Oppenheim JJ, Kwak LW (December 2001). "Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens". Journal of Immunology. 167 (11): 6644–53. doi:10.4049/jimmunol.167.11.6644. PMID 11714836.
- Bauer F, Schweimer K, Klüver E, Conejo-Garcia JR, Forssmann WG, Rösch P, Adermann K, Sticht H (December 2001). "Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity". Protein Science. 10 (12): 2470–9. doi:10.1110/ps.24401. PMC 2374044. PMID 11714914.
- Takahashi A, Wada A, Ogushi K, Maeda K, Kawahara T, Mawatari K, Kurazono H, Moss J, Hirayama T, Nakaya Y (November 2001). "Production of beta-defensin-2 by human colonic epithelial cells induced by Salmonella enteritidis flagella filament structural protein". FEBS Letters. 508 (3): 484–8. doi:10.1016/S0014-5793(01)03088-5. PMID 11728477.
- Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, McCray PB, Tack BF, Vogel HJ (March 2002). "The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus". The Journal of Biological Chemistry. 277 (10): 8279–89. doi:10.1074/jbc.M108830200. PMID 11741980.
 | This protein-related article is a stub. You can help Wikipedia by expanding it. |